SCHEMBL1427958

SCHEMBL1427958

COc1cc(C)cc(O)c1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.70
▸ MAPT P10636 3/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ POLB P06746 2/20 0.57
▸ RECQL P46063 2/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ APEX1 P27695 1/20 0.57
▸ MPI P34949 1/20 0.57
▸ TPMT P51580 1/20 0.55
▸ CYP3A4 P08684 1/20 0.54
▸ PTPN1 P18031 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.50
▸ ERN1 O75460 1/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ SELL P14151 1/20 0.44
▸ SELP P16109 1/20 0.44
▸ SELE P16581 1/20 0.44
▸ TUBB1 Q9H4B7 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29421895 1.00 ACHE (0.70) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL19034740 0.88 ACHE (0.59) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL68928 0.85 TDP1 (0.67) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL171116 0.83 ACHE (1.00) ACHEMAPTKMT2AKDM4EALDH1A1
SCHEMBL10053939 0.81 SELL (0.62) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL10053941 0.81 ACHE (0.50) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL31496789 0.79 ACHE (0.52) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL8084791 0.79 TDP1 (0.52) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL31090180 0.79 PTPN1 (0.53) ACHEMAPTKMT2AKDM4EPOLB
SCHEMBL5727264 0.79 ACHE (0.52) ACHEMAPTKMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101333158-B Method for preparing idebenone Suzhou lixin pharmaceutical co ltd 2010-07-21 — — CN claimed
CN-101333158-A Method for preparing idebenone SUZHOU LIXIN PHARMACEUTICAL CO (CN) 2008-12-31 — — CN claimed
EP-4153555-B1 PHOTOOXIDATION OF PHENOLIC COMPOUNDS DSM IP ASSETS BV (NL) 2024-01-31 — — EP disclosed
EP-4153555-A1 PHOTOOXIDATION OF PHENOLIC COMPOUNDS DSM IP Assets B.V. (NL) 2023-03-29 — — EP disclosed
CN-115667201-A Photooxidation of phenolic compounds 帝斯曼知识产权资产管理有限公司 2023-01-31 — — CN disclosed
WO-2021234080-A1 PHOTOOXIDATION OF PHENOLIC COMPOUNDS DSM IP ASSETS B.V. (NL) 2021-11-25 — — WO disclosed
EP-2483226-B1 METHOD FOR SEPARATING SALIFIED PHENOLIC COMPOUNDS RHODIA OPERATIONS (FR) 2017-07-26 — — EP disclosed
EP-2443123-B1 SMALL MOLECULE INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) RIGEL PHARMACEUTICALS INC (US) 2017-04-05 — — EP disclosed
US-9522145-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-12-20 — — US disclosed
US-9403745-B2 Method for separating salified phenolic compounds RHODIA OPERATIONS (FR) 2016-08-02 — — US disclosed
US-20160143898-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-05-26 — — US disclosed
EP-0443533-B1 Positive photoresist composition FUJI PHOTO FILM CO LTD (JP) 1998-09-30 — — EP disclosed
CN-1146761-A Method for carboxylating a phenol ether RHONE POULENC CHIMIE (FR) 1997-04-02 — — CN disclosed
EP-0756588-A1 METHOD FOR CARBOXYLATING A PHENOL ETHER RHONE-POULENC CHIMIE (FR) 1997-02-05 — — EP disclosed
CN-1033855-C Reduction of carboxylic esters TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-01-22 — — CN disclosed
WO-1996026176-A1 METHOD FOR CARBOXYLATING A PHENOL ETHER RHONE-POULENC CHIMIE (FR) 1996-08-29 — — WO disclosed
EP-0443533-A2 Positive photoresist composition FUJI PHOTO FILM CO., LTD. (JP) 1991-08-28 — — EP disclosed
US-4559177-A HYPOTENSIVE, CARDIOTONIC AND ANTIPHYLATIC AGENTS; ANTIALLERGENS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-12-17 — — US disclosed
EP-0021841-A2 2,3-Dialkoxy-1,4-quinone derivatives; method of producing 1,4-quinone derivatives Takeda Chemical Industries, Ltd. (JP) 1981-01-07 — — EP disclosed
US-4208426-A Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases EISAI CO., LTD. (JP) 1980-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143898-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ACHE 4616/4885MAPT 4509/4885KMT2A 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback